Physician profile
Eric D Jaakola
NPI 1104818061
$14,036.32
in general payments reported to CMS, 2019-2025
32 companies · $2,364 in 2025
The $2,364 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,312 · 2020: $1,203 · 2021: $544 · 2022: $1,824 · 2023: $1,006 · 2024: $784 · 2025: $2,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,679 · Travel and Lodging: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,678.79 |
| Travel and Lodging | $1,474.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $4,663.42 | 2019-2022 | |
| Paragon 28, INC. | $1,971.52 | 2019-2024 | Portfolio, Mtp |
| Smith+Nephew, INC. | $1,499.80 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix |
| Musculoskeletal Transplant Foundation INC. | $1,487.91 | 2024-2025 | |
| Stryker Corporation | $938.26 | 2022 | |
| Gemini Mountain Medical, LLC | $907.07 | 2020 | |
| Anika Therapeutics, INC. | $563.11 | 2022 | |
| Paratek Pharmaceuticals, INC. | $413.10 | 2021-2023 | Nuzyra |
| Treace Medical Concepts, INC. | $238.19 | 2022-2025 | |
| Osiris Therapeutics INC. | $163.64 | 2019 | |
| Medtronic, INC. | $155.16 | 2025 | Hawkone |
| Axogen | $114.55 | 2019 | |
| Misonix INC | $113.67 | 2020 | |
| Rikco International, LLC | $88.00 | 2019 | |
| Horizon Therapeutics Plc | $83.27 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Medical INC. | $81.85 | 2019 | |
| Bioventus LLC | $70.61 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $66.64 | 2023-2025 | Physio-Stim |
| Flower Orthopedics Coporation | $63.38 | 2022 | |
| Ossio INC | $62.12 | 2023 | |
| Nevro Corp. | $44.58 | 2022 | |
| Aroa Biosurgery Incorporated | $34.02 | 2024 | |
| Amgen INC. | $27.93 | 2024 | Krystexxa |
| Ossur Americas, INC. | $27.82 | 2025 | |
| Solventum Corporation | $24.34 | 2024 | V.A.C.Ulta |
| Boston Scientific Corporation | $23.83 | 2023 | |
| Acera Surgical, INC. | $22.76 | 2023 | Restrata Wound Matrix |
| Organogenesis INC. | $21.34 | 2021 | |
| Arteriocyte Medical Systems, INC. | $19.24 | 2019 | |
| Ani Pharmaceuticals, INC. | $18.32 | 2025 | Purified Cortrophin Gel |
| Kci USA, INC. | $13.74 | 2023 | Prevena |
| Zimmer Biomet Holdings, INC. | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Jaakola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.